Financial markets blog ZeroHedge reported on X on Tuesday, November 3, 2026, at 03:17:48 UTC, the details of a major capital raise by Oracle. The post stated: "Oracle announces pricing of concurrent underwritten public offerings of 86,206,897 shares of common stock, at a public offering price of $116.00 per share and $2,000,000,000 of its 7.000% notes due 2029, $1,750,000,000 of its 7.450% notes due 2031, $2,250,000,000 of its 7.850% notes due 2033, $2,500,000,000 of its 8.000% notes due 2037 and $1,500,000,000 of its 8.650% notes due 2046".
This announcement confirms the large-scale financing activity by the tech giant. Gokhshtein Media previously reported on Oracle's $10 billion stock sale, noting that the $116 price point for the shares could act as a support level. The offering includes both equity and a series of notes with varying maturities and interest rates, indicating a comprehensive approach to capital management. The public offering of shares occurred at an 11% discount to Friday's closing price, according to other reports.
The implications of this significant capital infusion are considerable for Oracle. The company is expected to leverage these funds for strategic initiatives, including further investments in artificial intelligence deployment. Investors will be watching Oracle's December earnings call closely for more details on how this capital will be utilized and its potential impact on future growth, especially in the competitive AI sector.
